APLP2 Antikörper (AA 340-450)
-
- Target Alle APLP2 Antikörper anzeigen
- APLP2 (Amyloid beta (A4) Precursor-Like Protein 2 (APLP2))
-
Bindungsspezifität
- AA 340-450
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser APLP2 Antikörper ist unkonjugiert
-
Applikation
- Immunohistochemistry (IHC), ELISA
- Kreuzreaktivität
- Human
- Aufreinigung
- Antigen Affinity Purified
- Immunogen
- Recombinant Human Amyloid-like protein 2 protein (340-450AA)
- Isotyp
- IgG
- Top Product
- Discover our top product APLP2 Primärantikörper
-
-
- Applikationshinweise
- Recommended dilution: IHC:1:20-1:200,
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- APLP2 (Amyloid beta (A4) Precursor-Like Protein 2 (APLP2))
- Andere Bezeichnung
- APLP2 (APLP2 Produkte)
- Synonyme
- HAI antikoerper, MT-SP1 antikoerper, MTSP1 antikoerper, PRSS14 antikoerper, SNC19 antikoerper, TADG15 antikoerper, TMPRSS14 antikoerper, APLP-2 antikoerper, APPH antikoerper, APPL2 antikoerper, CDEBP antikoerper, AI790698 antikoerper, Apph antikoerper, WALPLP2 antikoerper, aplp2 B antikoerper, APLP2 antikoerper, si:dkey-11k4.3 antikoerper, aplp2 A antikoerper, MGC86389 antikoerper, suppression of tumorigenicity 14 antikoerper, amyloid beta precursor like protein 2 antikoerper, amyloid beta (A4) precursor-like protein 2 antikoerper, amyloid beta (A4) precursor-like protein 2 S homeolog antikoerper, amyloid beta (A4) precursor-like protein 2 L homeolog antikoerper, ST14 antikoerper, APLP2 antikoerper, Aplp2 antikoerper, aplp2.S antikoerper, aplp2 antikoerper, aplp2.L antikoerper
- Hintergrund
-
Background: May play a role in the regulation of hemostasis. The soluble form may have inhibitory properties towards coagulation factors. May interact with cellular G-protein signaling pathways. May bind to the DNA 5\\\'-GTCACATG-3\\\'(CDEI box). Inhibits trypsin, chymotrypsin, plasmin, factor XIA and plasma and glandular kallikrein. Modulates the Cu/Zn nitric oxide-catalyzed autodegradation of GPC1 heparan sulfate side chains in fibroblasts.
Aliases: amyloid beta (A4) precursor like protein 2 antibody, Amyloid like protein 2 antibody, Amyloid precursor protein homolog HSD 2 antibody, amyloid precursor protein homolog HSD2 antibody, Amyloid protein homolog antibody, Amyloid-like protein 2 antibody, APLP-2 antibody, Aplp2 antibody, APLP2_HUMAN antibody, APPH antibody, APPL2 antibody, CDEBP antibody, CDEI box binding protein antibody, CDEI box-binding protein antibody
- UniProt
- Q06481
- Pathways
- EGFR Signaling Pathway, Transition Metal Ion Homeostasis, Feeding Behaviour
-